Product Program year 2020 Source: CMS Open Payments

Optisure Defibrillation ICD Lead

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$87,316

326 payments

Research payments

$0

0 payments

Through program year 2020, $87,316 in general payments and $0 in research payments were reported against Optisure Defibrillation ICD Lead (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $19,952 124
2019 General $67,364 202

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $87,316 326 payments
Top recipients General payments · program year 2020
  1. Andrew Epstein General Practice · Tucson, AZ $6,525 33% · 15 payments
  2. Marc Roelke Clinical Cardiac Electrophysiology · West Orange, NJ $4,050 20% · 5 payments
  3. Stephen Fahrig Clinical Cardiac Electrophysiology · Nashville, TN $3,285 16% · 4 payments
  4. Richard Borge Clinical Cardiac Electrophysiology · Horsham, PA $1,146 6% · 1 payment
  5. Matthew Trojan Cardiovascular Disease · Springfield, OR $748 4% · 1 payment

The top 5 of 80 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Clinical Cardiac Electrophysiology Internal Medicine $10,651 53% · 36 practitioners
  2. General Practice $6,525 33% · 1 practitioner
  3. Cardiovascular Disease Internal Medicine $1,540 8% · 20 practitioners
  4. Interventional Cardiology Internal Medicine $657 3% · 8 practitioners
  5. Internal Medicine $235 1% · 5 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Arizona $6,857 34% · 4 recipients
  2. New Jersey $4,087 20% · 5 recipients
  3. Tennessee $3,285 16% · 1 recipient
  4. California $1,573 8% · 14 recipients
  5. Pennsylvania $1,146 6% · 1 recipient

The top 5 of 23 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

326 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record